Trial intelligence / Profile preview

Effect of esketamine on postoperative sleep quality in gynecological laparoscopic surgery

ChiCTR2100048587Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Zhengzhou University
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in Postoperative sleep disturbance (PSD) and postoperative pain (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Postoperative sleep quality, Static VAS pain score and 3 more. Started Oct 2021; status: recruiting.

02

Drugs

esketamine
03

Conditions

Postoperative sleep disturbance (PSD)postoperative pain

Beyond the preview

Go deeper on ChiCTR2100048587.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100048587.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call